Top Sell
| Wertpapier | Buy | Sell | Buy (1W) | Sell (1W) ▼ | Kurs | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| T2 Biosystems Inc. | 0 | 4 | 0 | 0 | 0,16 € | - | - |
| Fate Therapeutics Inc. | 3 | 3 | 0 | 0 | 3,32 € | 7,31 € | 120,06 % |
| Synthetic Biologics Inc. | 0 | 1 | 0 | 0 | 0,12 € | - | - |
| Medigene AG | 1 | 1 | 0 | 0 | 1,06 € | - | - |
| Amarin Corp. ADR | 2 | 1 | 0 | 0 | 0,57 € | - | - |
| Viking Therapeutics Inc | 4 | 1 | 0 | 0 | 52,90 € | - | - |
| Protalix Biotherapeutics Inc. | 1 | 1 | 0 | 0 | 0,96 € | 2,00 € | 108,29 % |
| Enzo Biochem. Inc. | 0 | 1 | 0 | 0 | 1,01 € | - | - |
| Intellia Therapeutics Inc | 15 | 1 | 0 | 0 | 19,58 € | 60,53 € | 209,13 % |
| Salarius Pharmaceuticals Inc. | 0 | 1 | 0 | 0 | 0,39 € | - | - |
| InVivo Therapeutics Holdings | 0 | 13 | 0 | 0 | 0,31 € | - | - |
| Pacific Biosciences of California Inc. | 10 | 4 | 0 | 0 | 1,21 € | 9,20 € | 660,50 % |
| Palisade Bio Inc. | 3 | 1 | 0 | 0 | 0,34 € | 21,06 € | 6072,33 % |
| Xenon Pharmaceuticals Inc. | 1 | 1 | 0 | 0 | 36,20 € | 50,00 € | 38,12 % |
| Uniqure B.V. | 1 | 2 | 0 | 0 | 5,05 € | 11,00 € | 117,82 % |
| Nevro Corp. | 1 | 4 | 0 | 0 | 5,50 € | 13,77 € | 150,38 % |
| Rocket Pharmaceuticals Inc | 2 | 1 | 0 | 0 | ? | 32,00 € | 96,20 % |
| Enlivex Therapeutics Ltd. | 0 | 1 | 0 | 0 | 1,12 € | - | - |
| Cytomx Therapeutics Inc | 2 | 1 | 0 | 0 | 1,02 € | 50,00 € | 4806,77 % |
| CareRx Corp. | 0 | 1 | 0 | 0 | 1,09 € | - | - |
| Agenus Inc. | 4 | 2 | 0 | 0 | 0,41 € | 37,02 € | 8846,83 % |
| Aspira Womens Health Inc. | 1 | 1 | 0 | 0 | 0,84 € | 4,99 € | 497,89 % |
| Owens & Minor Inc. | 3 | 3 | 0 | 0 | 13,90 € | 24,04 € | 72,97 % |
| Bellicum Pharmaceuticals Inc. | 0 | 10 | 0 | 0 | 0,064 € | - | - |
| Syros Pharmaceuticals Inc. | 9 | 1 | 0 | 0 | 1,41 € | 12,01 € | 751,45 % |